StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3017% above fair value
$367.13−1.75 (-0.47%)

Close on Nov 20, 2026Market cap $29.81BP/E 30.1Yield 0.78%

Labcorp net income

Net income is the profit left for shareholders after every expense, interest and tax.

Labcorp's net income for the twelve months ending Sep 30, 2026 was $1.00B, up 17.4% year over year. For fiscal 2025 it was $876.50M, up 17.5% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $2.38B in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$876.50M+17.5%
FY2024Dec 31, 2024$746.00M+78.5%
FY2023Dec 31, 2023$418.00M-67.3%
FY2022Dec 31, 2022$1.28B-46.2%
FY2021Dec 31, 2021$2.38B+52.8%
FY2020Dec 31, 2020$1.56B+88.9%
FY2019Dec 31, 2019$823.80M-6.8%
FY2018Dec 31, 2018$883.70M-28.0%
FY2017Dec 31, 2017$1.23B+72.4%
FY2016Dec 31, 2016$711.80M+62.7%
FY2015Dec 31, 2015$437.60M-14.4%
FY2014Dec 31, 2014$511.20M-10.9%
FY2013Dec 31, 2013$573.80M-1.6%
FY2012Dec 31, 2012$583.10M+12.2%
FY2011Dec 31, 2011$519.70M-6.9%
FY2010Dec 31, 2010$558.20M+2.7%
FY2009Dec 31, 2009$543.30M+17.0%
FY2008Dec 31, 2008$464.50M-2.6%
FY2007Dec 31, 2007$476.80M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$262.80M+0.7%
Q2 FY2026Jun 30, 2026$298.70M+25.6%
Q1 FY2026Mar 31, 2026$277.80M+30.5%
Q4 FY2025Dec 31, 2025$164.70M+14.9%
Q3 FY2025Sep 30, 2025$261.10M+54.2%
Q2 FY2025Jun 30, 2025$237.90M+15.9%
Q1 FY2025Mar 31, 2025$212.80M-6.7%
Q4 FY2024Dec 31, 2024$143.40M–
Q3 FY2024Sep 30, 2024$169.30M-7.6%
Q2 FY2024Jun 30, 2024$205.30M+8.7%
Q1 FY2024Mar 31, 2024$228.00M+7.1%
Q4 FY2023Dec 31, 2023-$167.10M-319.6%
Q3 FY2023Sep 30, 2023$183.30M-48.0%
Q2 FY2023Jun 30, 2023$188.90M-47.3%
Q1 FY2023Mar 31, 2023$212.90M-56.7%
Q4 FY2022Dec 31, 2022$76.10M-86.2%
Q3 FY2022Sep 30, 2022$352.80M-39.9%
Q2 FY2022Jun 30, 2022$358.60M-23.3%
Q1 FY2022Mar 31, 2022$491.60M-36.1%
Q4 FY2021Dec 31, 2021$553.00M-41.1%
Q3 FY2021Sep 30, 2021$587.30M-16.5%
Q2 FY2021Jun 30, 2021$467.40M+101.8%
Q1 FY2021Mar 31, 2021$769.60M–
Q4 FY2020Dec 31, 2020$938.30M+313.2%
Q3 FY2020Sep 30, 2020$703.40M–
Q2 FY2020Jun 30, 2020$231.60M+21.6%
Q1 FY2020Mar 31, 2020-$317.20M-270.9%
Q4 FY2019Dec 31, 2019$227.10M+43.8%
Q3 FY2019Sep 30, 2019-$317.20M-199.5%
Q2 FY2019Jun 30, 2019$190.40M-18.6%
Q1 FY2019Mar 31, 2019$185.60M+7.2%
Q4 FY2018Dec 31, 2018$157.90M-77.0%
Q3 FY2018Sep 30, 2018$318.80M+85.9%
Q2 FY2018Jun 30, 2018$233.80M+26.5%
Q1 FY2018Mar 31, 2018$173.20M-5.4%
Q4 FY2017Dec 31, 2017$687.80M+273.0%
Q3 FY2017Sep 30, 2017$171.50M–
Q2 FY2017Jun 30, 2017$184.80M–
Q1 FY2017Mar 31, 2017$183.00M–
Q4 FY2016Dec 31, 2016$184.40M–

More Labcorp figures

See a number that looks wrong?